Interventions that Improve Body and Brain Bioenergetics for Parkinson's Disease Risk Reduction and Therapy

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Parkinson's Disease

• Publication date

  2014-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3233/JPD-130335PMID 24473219
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fasting: molecular mechanisms and clinical applications.

  2014cited by this paper
• BDNF and Exercise Enhance Neuronal DNA Repair by Stimulating CREB-Mediated Production of Apurinic/Apyrimidinic Endonuclease 1

  2014cited by this paper
• Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice.

  2014cited by this paper
• Exenatide and the treatment of patients with Parkinson's disease.

  2013cited by this paper
• Bridging animal and human models of exercise-induced brain plasticity.

  2013cited by this paper
• Deep brain stimulation of the subthalamic nucleus regulates postabsorptive glucose metabolism in patients with Parkinson's disease.

  2013cited by this paper
• Dietary restriction supports peripheral nerve health by enhancing endogenous protein quality control mechanisms.

  2013cited by this paper
• Alzheimer's disease and insulin resistance: translating basic science into clinical applications.

  2013cited by this paper
• Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession.

  2013cited by this paper
• Exercise modifies α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor expression in striatopallidal neurons in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned mouse

  2013cited by this paper
• Caudo-rostral brain spreading of α-synuclein through vagal connections

  2013cited by this paper
• Shared dysregulated pathways lead to Parkinson's disease and diabetes.

  2013cited by this paper
• Mechanisms governing the health and performance benefits of exercise

  2013cited by this paper
• The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations

  2013cited by this paper
• Parkinson's disease, insulin resistance and novel agents of neuroprotection.

  2013cited by this paper
• A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease.

  2013cited by this paper
• Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease.

  2013cited by this paper
• Dietary energy intake modifies brainstem autonomic dysfunction caused by mutant α-synuclein.

  2013cited by this paper
• Head injury and risk of Parkinson disease: A systematic review and meta‐analysis

  2013cited by this paper
• AMPK and Exercise: Glucose Uptake and Insulin Sensitivity

  2013cited by this paper
• High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice.

  2012cited by this paper
• Long-term exercise treatment reduces oxidative stress in the hippocampus of aging rats.

  2012cited by this paper
• Energy intake and exercise as determinants of brain health and vulnerability to injury and disease.

  2012cited by this paper
• Full and partial peroxisome proliferation-activated receptor-γ agonists, but not δ agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expression.

  2012cited by this paper
• Neuroprotective actions of Glucagon‐like peptide‐1 in differentiated human neuroprogenitor cells

  2012influential reference
• Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis

  2012cited by this paper
• Involvement of PGC-1α in the formation and maintenance of neuronal dendritic spines

  2012cited by this paper
• Genetically engineered mouse models of Parkinson's disease.

  2012cited by this paper
• Diabetes and cognitive dysfunction.

  2012cited by this paper
• Dementia is associated with insulin resistance in patients with Parkinson's disease.

  2012cited by this paper
• Ketogenic diets: new advances for metabolism-based therapies.

  2012cited by this paper
• Recruiting adaptive cellular stress responses for successful brain ageing

  2012cited by this paper
• Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort.

  2012cited by this paper
• The role of CaMKII in regulating GLUT4 expression in skeletal muscle.

  2012cited by this paper
• Disruption of protein quality control in Parkinson's disease.

  2012cited by this paper
• GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus

  2012cited by this paper
• Exercise Does Not Protect against MPTP-Induced Neurotoxicity in BDNF Happloinsufficent Mice

  2012cited by this paper
• Of mice and men: The benefits of caloric restriction, exercise, and mimetics

  2012cited by this paper
• The Diabetes Drug Liraglutide Ameliorates Aberrant Insulin Receptor Localisation and Signalling in Parallel with Decreasing Both Amyloid-β Plaque and Glial Pathology in a Mouse Model of Alzheimer’s Disease

  2012cited by this paper
• Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease.

  2011cited by this paper
• Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson’s disease with moderate neurodegeneration

  2011cited by this paper
• Exercise alleviates Parkinsonism: clinical and laboratory evidence

  2011cited by this paper
• Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

  2011cited by this paper
• Serum insulinlike growth factor 1 as possible marker for risk and early diagnosis of Parkinson disease.

  2011cited by this paper
• Synuclein deposition and non-motor symptoms in Parkinson disease.

  2011cited by this paper
• Recent advances in the genetics of Parkinson's disease.

  2011cited by this paper
• Sensing of energy and nutrients by AMP-activated protein kinase.

  2011cited by this paper
• Sir-2.1 modulates 'calorie-restriction-mediated' prevention of neurodegeneration in Caenorhabditis elegans: implications for Parkinson's disease.

  2011cited by this paper
• CREB: a multifaceted regulator of neuronal plasticity and protection

  2011cited by this paper
• The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease

  2011cited by this paper
• Diabetes and the Risk of Developing Parkinson’s Disease in Denmark

  2011cited by this paper
• Etiology and pathogenesis of Parkinson's disease

  2011cited by this paper
• Obesity, diabetes, and risk of Parkinson's disease

  2011cited by this paper
• Running wheel activity restores MPTP-induced functional deficits

  2011cited by this paper
• Exercise training increases mitochondrial biogenesis in the brain.

  2011cited by this paper
• Short bouts of mild-intensity physical exercise improve spatial learning and memory in aging rats: involvement of hippocampal plasticity via AKT, CREB and BDNF signaling.

  2011cited by this paper
• Insulin resistance impairs nigrostriatal dopamine function.

  2011cited by this paper
• The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women

  2011cited by this paper
• The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys

  2011cited by this paper
• How might physical activity benefit patients with Parkinson disease?

  2011cited by this paper
• Rosiglitazone decreases peroxisome proliferator receptor-γ levels in microglia and inhibits TNF-α production: new evidences on neuroprotection in a progressive Parkinson's disease model.

  2011cited by this paper
• Does vigorous exercise have a neuroprotective effect in Parkinson disease?

  2011cited by this paper
• What genetics tells us about the causes and mechanisms of Parkinson's disease.

  2011cited by this paper
• Age and energy intake interact to modify cell stress pathways and stroke outcome

  2010cited by this paper
• “Control” laboratory rodents are metabolically morbid: Why it matters

  2010cited by this paper
• Exercise is not beneficial and may accelerate symptom onset in a mouse model of Huntington’s disease

  2010cited by this paper
• Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: In vivo imaging with [18F]fallypride

  2010cited by this paper
• Brain stem pathology in Parkinson's disease: An evaluation of the Braak staging model

  2010cited by this paper
• GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease

  2010cited by this paper
• Physical activities and future risk of Parkinson disease

  2010cited by this paper
• Exercise protects against MPTP-induced neurotoxicity in mice.

  2010cited by this paper
• Skeletal muscle autophagy and apoptosis during aging: effects of calorie restriction and life-long exercise.

  2010cited by this paper
• The effect of exercise and nutrition on intramuscular fat metabolism and insulin sensitivity.

  2010cited by this paper
• Endurance exercise training promotes angiogenesis in the brain of chronic/progressive mouse model of Parkinson's Disease

  2010cited by this paper
• Physical exercise for the prevention and treatment of type 2 diabetes.

  2010cited by this paper
• Caloric restriction: from soup to nuts.

  2010cited by this paper
• Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease.

  2009cited by this paper
• Effects of voluntary and forced exercise on plaque deposition, hippocampal volume, and behavior in the Tg2576 mouse model of Alzheimer's disease.

  2009cited by this paper
• Improved Insulin Sensitivity After Exercise: Focus on Insulin Signaling

  2009cited by this paper
• Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice

  2009cited by this paper
• Exendin-4 Improves Glycemic Control, Ameliorates Brain and Pancreatic Pathologies, and Extends Survival in a Mouse Model of Huntington's Disease

  2009cited by this paper
• GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism

  2009cited by this paper
• Combination therapy with Coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s Diseases

  2009cited by this paper
• Weight loss, body fat mass, and leptin in Parkinson's disease

  2009cited by this paper
• Exercise programs improve mobility and balance in people with Parkinson's disease.

  2009cited by this paper
• Nicotinamide Prevents NAD+ Depletion and Protects Neurons Against Excitotoxicity and Cerebral Ischemia: NAD+ Consumption by SIRT1 may Endanger Energetically Compromised Neurons

  2009cited by this paper
• The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies.

  2009cited by this paper
• The Exercise-Induced Stress Response of Skeletal Muscle, with Specific Emphasis on Humans

  2009cited by this paper
• Progression of Parkinson's disease in the clinical phase: potential markers.

  2009cited by this paper
• The Role of Incretins in Glucose Homeostasis and Diabetes Treatment

  2008cited by this paper
• Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington's disease

  2008cited by this paper
• Brain‐derived neurotrophic factor functions as a metabotrophin to mediate the effects of exercise on cognition

  2008cited by this paper
• Broad neuroprotective profile of nicotinamide in different mouse models of MPTP‐induced parkinsonism

  2008cited by this paper
• The effect of exercise training in improving motor performance and corticomotor excitability in people with early Parkinson's disease.

  2008cited by this paper
• The PPARγ agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B

  2008cited by this paper
• Peroxisome proliferator-activated receptor gamma agonists as insulin sensitizers: from the discovery to recent progress.

  2008cited by this paper
• Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons

  2008cited by this paper
• Neurogenesis and Exercise: Past and Future Directions

  2008cited by this paper
• Dietary restriction does not prevent nigrostriatal degeneration in the 6-hydroxydopamine model of Parkinson's disease.

  2008cited by this paper
• Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease.

  2007cited by this paper

• A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease

  2025cites this paper
• A prebiotic diet intervention can restore faecal short chain fatty acids in Parkinson's Disease yet fails to restore the gut microbiome homeostasis

  2024cites this paper
• Effects of Caloric Restriction and Intermittent Fasting and Their Combined Exercise on Cognitive Functioning: A Review

  2024cites this paper
• Treadmill Exercise Testing on Different Blood Genotypes among University Students

  2023cites this paper
• Pain and Parkinson's disease: Current mechanism and management updates

  2023cites this paper
• Intermittent Fasting on Neurologic Diseases: Potential Role of Gut Microbiota

  2023cites this paper
• Targeting sleep and the circadian system as a novel treatment strategy for Parkinson’s disease

  2023cites this paper
• Fasting: From Physiology to Pathology

  2023cites this paper
• POTENTIAL PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISORDERS BY OLIVE POLYPHENOLS AND HYDROX.

  2022cites this paper
• State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions.

  2022cites this paper
• The mechanism of exercise for pain management in Parkinson’s disease

  2022cites this paper
• Applying available knowledge and resources to alleviate familial and sporadic neurodegenerative disorders.

  2021cites this paper
• Preventing and Treating of Parkinson’s Disease with a Plant-Based Diet

  2021influential citation
• Lycopene suppresses palmitic acid-induced brain oxidative stress, hyperactivity of some neuro-signalling enzymes, and inflammation in female Wistar rat

  2021cites this paper
• The Pleiotropic Potential of BDNF beyond Neurons: Implication for a Healthy Mind in a Healthy Body

  2021cites this paper
• Possible Neuroprotective Mechanisms of Physical Exercise in Neurodegeneration

  2020cites this paper
• Restricted feeding benefits the growth performance and glucose homeostasis of blunt snout bream Megalobrama amblycephala fed high-carbohydrate diets

  2020cites this paper
• Does calorie restriction improve cognition?

  2020cites this paper
• Prediction equation for estimating cognitive function using physical fitness parameters in older adults

  2020cites this paper
• Parkinson’s Disease–Mild Cognitive Impairment (PD-MCI): A Useful Summary of Update Knowledge

  2019cites this paper
• Diet in Parkinson's Disease: Critical Role for the Microbiome

  2019influential citation
• Obesity: An outcome of abnormal eating behavior

  2018cites this paper
• Fasting and Fast Food Diet Play an Opposite Role in Mice Brain Aging

  2018cites this paper
• Health Benefits of Exercise.

  2018cites this paper
• Prevention of progression in Parkinson’s disease

  2018cites this paper
• Conditioning Against the Pathology of Parkinson's disease.

  2018cites this paper
• Epidemiology of Parkinson's Disease—East Versus West

  2018cites this paper
• The Benefits of Physical Activity on Brain Structure and Function in Healthy Aging and Age‐Related Neurological Disease

  2018cites this paper
• Fasting and Fast Food Diet Play an Opposite Role in Mice Brain Aging

  2018cites this paper
• Understanding and Treating Pain Syndromes in Parkinson's Disease.

  2017cites this paper
• Brain metabolism in health, aging, and neurodegeneration

  2017cites this paper
• Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance.

  2017cites this paper
• Aerobic-Strength Exercise Improves Metabolism and Clinical State in Parkinson’s Disease Patients

  2017cites this paper
• Calorie restriction in rodents: Caveats to consider.

  2017cites this paper
• Exercise increases mitochondrial complex I activity and DRP1 expression in the brains of aged mice

  2017cites this paper
• Neuroprotective Effects of Eexenatide in a Rotenone‐Induced Rat Model of Parkinson's Disease☆

  2017cites this paper
• Parkinson disease: Exenatide – a drug for diabetes and Parkinson disease?

  2017cites this paper
• Unraveling the metabolic health benefits of fasting related to religious beliefs: A narrative review.

  2017cites this paper
• Focus : Metabolism Brain metabolism in health , aging , and neurodegeneration

  2017cites this paper
• Combined immunotherapy with “anti-insulin resistance” therapy as a novel therapeutic strategy against neurodegenerative diseases

  2017cites this paper
• Initiation of calorie restriction in middle-aged male rats attenuates aging-related motoric decline and bradykinesia without increased striatal dopamine.

  2016cites this paper
• Parkinson’s Disease and Aging

  2016cites this paper
• The Chronic Exercise–Cognition Interaction

  2016cites this paper
• Emerging preclinical pharmacological targets for Parkinson's disease

  2016cites this paper
• Exercise and Nutritional Benefits in PD: Rodent Models and Clinical Settings.

  2016cites this paper
• Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson’s disease

  2016cites this paper
• Mechanisms of neurodegeration in type 2 diabetes and the neuroprotective potential of dipeptidyl peptidase 4 inhibitors.

  2015cites this paper
• The Rationale for Exercise in the Management of Pain in Parkinson’s Disease

  2015cites this paper
• protein Proteotoxicity and Cardiac Dysfunction

  2015cites this paper
• Exercise and Dietary Restriction for Promotion of Neurohealth Benefits

  2015cites this paper
• PUBLISHED VERSION

  2015cites this paper
• Effects of physical exercise on central nervous system functions: a review of brain region specific adaptations

  2015cites this paper
• Effects of exercise on brain functions in diabetic animal models.

  2015cites this paper
• Basic science breaks through: New therapeutic advances in Parkinson's disease

  2015cites this paper
• Proteotoxicity and cardiac dysfunction.

  2015cites this paper
• Interventions to Slow Aging in Humans: Are We Ready?

  2015cites this paper
• When brawn benefits brain: physical activity and Parkinson's disease risk.

  2015cites this paper
• The emerging role of nutrition in Parkinson's disease

  2014cites this paper
• Is Exenatide the Next Big Thing in Parkinson's Disease?

  2014cites this paper
• Cardiometabolic Disease in Parkinson’s Disease High or Low Risk — A Risk Worth Protecting?

  2014cites this paper
• Journal of Molecular Psychiatry

  2013cites this paper
• McLendon and Robbins Protein Misfolding

  year unknowncites this paper